Advertisement
Research Article

Inhibition of Endothelial Activation: A New Way to Treat Cerebral Malaria?

  • Samuel C Wassmer,

    Affiliation: CNRS UMR 6020, Immunopathology Group, IFR 48, Faculty of Medicine, Université de la Méditerranée, Marseille, France

    ¤ Current address: Malawi-Liverpool-Wellcome Trust Clinical Research Programme, Queen Elizabeth Central Hospital, Chichiri, Blantyre, Malawi

    X
  • George J Cianciolo,

    Affiliation: Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America

    X
  • Valéry Combes,

    Affiliation: CNRS UMR 6020, Immunopathology Group, IFR 48, Faculty of Medicine, Université de la Méditerranée, Marseille, France

    X
  • Georges E Grau mail

    To whom correspondence should be addressed. E-mail: georges.grau@medecine.univ-mrs.fr

    Affiliation: CNRS UMR 6020, Immunopathology Group, IFR 48, Faculty of Medicine, Université de la Méditerranée, Marseille, France

    X
  • Published: August 23, 2005
  • DOI: 10.1371/journal.pmed.0020245

About the Authors

Samuel C Wassmer, Valéry Combes, Georges E Grau
CNRS UMR 6020, Immunopathology Group, IFR 48, Faculty of Medicine, Université de la Méditerranée, Marseille, France
George J Cianciolo
Department of Pathology, Duke University Medical Center, Durham, North Carolina, United States of America

Corresponding Author

Email: georges.grau@medecine.univ-mrs.fr

Competing Interests

GJC has financial ties to LeukoMed.

Author Contributions

GEG and GJC designed the study. SCW performed the experiments. SCW, VC and GEG analyzed the data. SCW, GJC, VC, and GEG contributed to writing the paper.